Since the beginning of the 20th century, the use of hyperbaric oxygen therapy (HBOT) has broadened considerably to encompass a wide range of indications including treatment for decompression sickness, radiation injury, severe anaemia and carbon monoxide poisoning.1,2
To practitioners of aesthetic medicine, HBOT is likely to be associated with the promotion of healing after invasive cosmetic surgery and with skin rejuvenation, as well as possible usage in the treatment of vascular compromise resulting from injection of dermal fillers; which will be the focus of this article.
Dermal filler use is growing in popularity. Figures from the US show a rise in the number of procedures from 1.5 million in 2007 to 2.6 million in 2018.3,4 Demand for non-invasive procedures using fillers is likewise reported to be growing in the UK.5 As usage increases, the incidence of complications arising from the injection of dermal fillers is reported to increase concurrently.6,7
Further, the move towards larger and deeper injections to achieve volume restoration, as well as increasing numbers of injections administered by non-experts, are also posited as contributing to the…
